Uncertainty directed factorial clinical trials.
Ontology highlight
ABSTRACT: The development and evaluation of novel treatment combinations is a key component of modern clinical research. The primary goals of factorial clinical trials of treatment combinations range from the estimation of intervention-specific effects, or the discovery of potential synergies, to the identification of combinations with the highest response probabilities. Most factorial studies use balanced or block randomization, with an equal number of patients assigned to each treatment combination, irrespective of the specific goals of the trial. Here, we introduce a class of Bayesian response-adaptive designs for factorial clinical trials with binary outcomes. The study design was developed using Bayesian decision-theoretic arguments and adapts the randomization probabilities to treatment combin
SUBMITTER: Kotecha G
PROVIDER: S-EPMC11247193 | biostudies-literature | 2024 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA